speb/financial-data huggingface dataset:
Financial ratios for BM.V — annual report dated 2025-04-30
Total revenue: 0
Operating income: -28551.44927536232
Net income: -6502.898550724638
Capital expenditures: 0
Operating cash flow: -7751.449275362319
Net tangible assets: 476701.44927536236
Owner earnings: -6502.898550724638
Return on net tangible assets (%): -1.364144908854325
Buffett classification: The Gruesome
Stock price: 0.05072463768115943
Shares outstanding: 34638067
Book value: 476701.44927536236
P/B ratio: 3.685752164633776
Market cap (USD): 1757003.398550725
Debt to equity: 0
Current ratio: 8.323902926718958
Quick ratio: 8.323902926718958
Free cash flow (dilution-adjusted): -7751.449275362319
Buyback yield (%): 0
Retained earnings: -29398488.405797105
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.989377485376561
Rule of 40 score: 0
Financial ratios for BM.V — quarterly report dated 2025-10-31
Total revenue: 0
Operating income: -2461.4285714285716
Net income: 8507.142857142857
Capital expenditures: 0
Operating cash flow: -13321.428571428572
Net tangible assets: 477983.5714285715
Owner earnings: 8507.142857142857
Return on net tangible assets (%): 1.779798169990899
Buffett classification: The Gruesome
Stock price: 0.13571428571428573
P/E ratio: 138.14510348446686
Shares outstanding: 34638067
Book value: 477983.5714285715
P/B ratio: 9.8348160949943
Market cap (USD): 4700880.521428572
Debt to equity: 0
Current ratio: 9.884484518543722
Quick ratio: 9.884484518543722
Free cash flow (dilution-adjusted): -13321.428571428572
Buyback yield (%): 0
Retained earnings: -28970417.85714286
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5149609146757883
Rule of 40 score: 0
Financial ratios for CF — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 64.37
Shares outstanding: 153629274
Market cap (USD): 9889116367.380001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CF — annual report dated 2022-12-31
Total revenue: 11186000000
Gross profit: 5861000000
Operating income: 5571000000
Net income: 3937000000
Capital expenditures: 452000000
Operating cash flow: 3855000000
Depreciation & amortization: 850000000
Net tangible assets: 2947000000
Owner earnings: 4335000000
Return on net tangible assets (%): 147.09874448591788
Capex to operating income (%): 8.113444623945432
Buffett classification: The Great
Stock price: 78.71
P/E ratio: 3.071414822590805
Shares outstanding: 153629274
Book value: 7853000000
P/B ratio: 1.5398141037234176
Market cap (USD): 12092160156.539999
Debt to equity: 0.41067108111549727
Current ratio: 3.691457286432161
Quick ratio: 3.215075376884422
Effective tax rate (%): 22.728164867517172
Interest coverage ratio: 16.580357142857142
COGS to revenue (%): 47.604148042195604
SG&A to revenue (%): 2.592526372251028
Free cash flow (dilution-adjusted): 3352000000
Buyback yield (%): 11.32965477023591
Retained earnings: 3867000000
Inventory turnover: 11.234177215189874
Receivables turnover: 19.219931271477662
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 45.22649780808573
FCF margin (%): 29.9660289647774
Rule of 40 score: 29.9660289647774
Financial ratios for CF — annual report dated 2023-12-31
Total revenue: 6631000000
Gross profit: 2545000000
Operating income: 2252000000
Net income: 1838000000
Capital expenditures: 1721000000
Operating cash flow: 2757000000
Depreciation & amortization: 869000000
Net tangible assets: 2684000000
Owner earnings: 986000000
Return on net tangible assets (%): 36.73621460506706
Capex to operating income (%): 76.42095914742451
Buffett classification: The Gruesome
Stock price: 74.98
P/E ratio: 6.267205094951033
Shares outstanding: 153629274
Book value: 8373000000
P/B ratio: 1.3757462038122537
Market cap (USD): 11519122964.52
Debt to equity: 0.3860026274931327
Current ratio: 3.8125
Quick ratio: 3.43875
Effective tax rate (%): 18.23843416370107
Interest coverage ratio: 15.63888888888889
COGS to revenue (%): 61.61966520886744
SG&A to revenue (%): 4.358316995928216
Free cash flow (dilution-adjusted): 996000000
Buyback yield (%): 5.226092314963713
Retained earnings: 4535000000
Inventory turnover: 13.665551839464882
Receivables turnover: 13.13069306930693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.588096641131408
FCF margin (%): 15.020358920223195
Revenue growth (%): -40.72054353656356
Rule of 40 score: -25.700184616340366
Financial ratios for CF — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82.51
Shares outstanding: 153629274
Market cap (USD): 12675951397.740002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CF — annual report dated 2024-12-31
Total revenue: 5936000000
Gross profit: 2056000000
Operating income: 1711000000
Net income: 1477000000
Capital expenditures: 513000000
Operating cash flow: 2271000000
Depreciation & amortization: 925000000
Net tangible assets: 1986000000
Owner earnings: 1889000000
Return on net tangible assets (%): 95.11581067472306
Capex to operating income (%): 29.98246639392168
Buffett classification: The Good
Stock price: 82.53
P/E ratio: 8.584308722559243
Shares outstanding: 153629274
Book value: 7592000000
P/B ratio: 1.6700505773472076
Market cap (USD): 12679023983.22
Debt to equity: 0.4275553213909378
Current ratio: 3.0806845965770173
Quick ratio: 2.6968215158924207
Effective tax rate (%): 16.174801362088537
Interest coverage ratio: 12.309352517985612
COGS to revenue (%): 65.36388140161725
SG&A to revenue (%): 5.3908355795148255
Free cash flow (dilution-adjusted): 1714000000
Buyback yield (%): 12.106610114717736
Retained earnings: 4009000000
Inventory turnover: 12.356687898089172
Receivables turnover: 14.693069306930694
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.527830487033524
FCF margin (%): 28.87466307277628
Revenue growth (%): -10.481073744533253
Rule of 40 score: 18.393589328243024
Financial ratios for CF — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82.53
Shares outstanding: 153629274
Market cap (USD): 12679023983.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CF — quarterly report dated 2025-03-31
Total revenue: 1663000000
Gross profit: 572000000
Operating income: 474000000
Net income: 351000000
Capital expenditures: 130000000
Operating cash flow: 586000000
Depreciation & amortization: 221000000
Net tangible assets: 1789000000
Owner earnings: 442000000
Return on net tangible assets (%): 24.706539966461712
Capex to operating income (%): 27.42616033755274
Buffett classification: The Good
Stock price: 76.06
P/E ratio: 8.322679900598292
Shares outstanding: 153629274
Book value: 7297000000
P/B ratio: 1.6013488530135673
Market cap (USD): 11685042580.44
Debt to equity: 0.45169247636014803
Current ratio: 2.5910543130990416
Quick ratio: 2.2172523961661343
Effective tax rate (%): 19.679633867276888
Interest coverage ratio: 13.542857142857143
COGS to revenue (%): 65.60432952495489
SG&A to revenue (%): 5.051112447384246
Free cash flow (dilution-adjusted): 444000000
Buyback yield (%): 3.9109827529853267
Retained earnings: 4208000000
Inventory turnover: 3.1082621082621085
Receivables turnover: 2.857388316151203
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8321610477807426
FCF margin (%): 26.698737221888152
Rule of 40 score: 26.698737221888152
Financial ratios for CF — quarterly report dated 2025-06-30
Total revenue: 1890000000
Gross profit: 755000000
Operating income: 646000000
Net income: 492000000
Capital expenditures: 241000000
Operating cash flow: 563000000
Depreciation & amortization: 232000000
Net tangible assets: 1982000000
Owner earnings: 483000000
Return on net tangible assets (%): 24.369323915237135
Capex to operating income (%): 37.306501547987615
Buffett classification: The Good
Stock price: 90.07
P/E ratio: 16.414458729750887
Shares outstanding: 153629274
Book value: 7821000000
P/B ratio: 1.7692607990256999
Market cap (USD): 13837388709.179998
Debt to equity: 0.4252653113412607
Current ratio: 3.2240963855421687
Quick ratio: 2.8433734939759034
Effective tax rate (%): 22.51968503937008
Interest coverage ratio: 19
COGS to revenue (%): 60.05291005291006
SG&A to revenue (%): 5.343915343915344
Free cash flow (dilution-adjusted): 305000000
Buyback yield (%): 1.5609881643109536
Retained earnings: 3924000000
Inventory turnover: 3.5917721518987342
Receivables turnover: 3.2252559726962455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5
FCF margin (%): 16.137566137566136
Revenue growth (%): 13.650030066145522
Rule of 40 score: 29.787596203711658
Financial ratios for CF — quarterly report dated 2025-09-30
Total revenue: 1659000000
Gross profit: 632000000
Operating income: 574000000
Net income: 460000000
Capital expenditures: 347000000
Operating cash flow: 1064000000
Depreciation & amortization: 217000000
Net tangible assets: 1877000000
Owner earnings: 330000000
Return on net tangible assets (%): 17.581246670218434
Capex to operating income (%): 60.45296167247387
Buffett classification: The Good
Stock price: 88.33
P/E ratio: 10.414484859877206
Shares outstanding: 153629274
Book value: 7695000000
P/B ratio: 1.76349236808577
Market cap (USD): 13570073772.42
Debt to equity: 0.4413255360623782
Current ratio: 2.2732824427480915
Quick ratio: 1.9931297709923663
Effective tax rate (%): 18.58407079646018
Interest coverage ratio: 15.513513513513514
COGS to revenue (%): 61.904761904761905
SG&A to revenue (%): 5.304400241109102
Free cash flow (dilution-adjusted): 704000000
Buyback yield (%): 2.660265567116527
Retained earnings: 4195000000
Inventory turnover: 2.7983651226158037
Receivables turnover: 2.755813953488372
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.452028232374157
FCF margin (%): 42.435201928872814
Revenue growth (%): -12.222222222222221
Rule of 40 score: 30.212979706650593
Financial ratios for CF — annual report dated 2025-12-31
Total revenue: 7084000000
Gross profit: 2724000000
Operating income: 2375000000
Net income: 1798000000
Capital expenditures: 944000000
Operating cash flow: 2752000000
Depreciation & amortization: 898000000
Net tangible assets: 1872000000
Owner earnings: 1752000000
Return on net tangible assets (%): 93.58974358974359
Capex to operating income (%): 39.747368421052634
Buffett classification: The Good
Stock price: 76.62
P/E ratio: 6.546760274682982
Shares outstanding: 153629274
Book value: 7775000000
P/B ratio: 1.513964626865595
Market cap (USD): 11771074973.880001
Debt to equity: 0.46765273311897104
Current ratio: 3.3652762119503947
Quick ratio: 2.9334836527621193
Effective tax rate (%): 19.696292987941042
Interest coverage ratio: 16.379310344827587
COGS to revenue (%): 61.54714850367024
SG&A to revenue (%): 5.138339920948617
Free cash flow (dilution-adjusted): 1756000000
Buyback yield (%): 11.715157732492564
Retained earnings: 3874000000
Inventory turnover: 11.383812010443863
Receivables turnover: 14.51639344262295
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.991061283236117
FCF margin (%): 24.78825522303783
Revenue growth (%): 19.339622641509436
Rule of 40 score: 44.127877864547266
Financial ratios for CF — quarterly report dated 2025-12-31
Total revenue: 1872000000
Gross profit: 765000000
Operating income: 681000000
Net income: 495000000
Capital expenditures: 226000000
Operating cash flow: 539000000
Depreciation & amortization: 228000000
Net tangible assets: 1872000000
Owner earnings: 497000000
Return on net tangible assets (%): 26.549145299145298
Capex to operating income (%): 33.186490455212926
Buffett classification: The Good
Stock price: 76.62
P/E ratio: 6.546760274682982
Shares outstanding: 153629274
Book value: 7775000000
P/B ratio: 1.513964626865595
Market cap (USD): 11771074973.880001
Debt to equity: 0.46765273311897104
Current ratio: 3.3652762119503947
Quick ratio: 2.9334836527621193
Effective tax rate (%): 17.774086378737543
Interest coverage ratio: 17.46153846153846
COGS to revenue (%): 59.13461538461539
SG&A to revenue (%): 4.861111111111112
Free cash flow (dilution-adjusted): 303000000
Buyback yield (%): 2.9309132833284517
Retained earnings: 3874000000
Inventory turnover: 2.8903394255874675
Receivables turnover: 3.8360655737704916
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.1587000984773885
FCF margin (%): 16.185897435897438
Revenue growth (%): 12.839059674502712
Rule of 40 score: 29.024957110400152
Financial ratios for CONFIPET.NS — annual report dated 2022-03-31
Total revenue: 188275089.01490176
Gross profit: 30644863.510483976
Operating income: 15736515.890808387
Net income: 11834366.345773442
Capital expenditures: 0
Operating cash flow: 13569827.245153634
Depreciation & amortization: 8802584.728999076
Net tangible assets: 77672425.16154556
Owner earnings: 20636951.074772518
Return on net tangible assets (%): 26.569211701387125
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8188052222075696
P/E ratio: 22.987348294929795
Shares outstanding: 332241043
Book value: 102183832.25636292
P/B ratio: 2.662267552831479
Market cap (USD): 272040701.04008967
Debt to equity: 0.12489998193222003
Current ratio: 1.2414188128473842
Quick ratio: 0.7684670541813399
Effective tax rate (%): 24.755112562295924
Interest coverage ratio: 16.213315217391305
COGS to revenue (%): 83.72335731146117
SG&A to revenue (%): 2.286911024101871
Free cash flow (dilution-adjusted): 13569827.245153634
Buyback yield (%): 0
Retained earnings: 39343267.83594883
Inventory turnover: 10.723154211895576
Receivables turnover: 21.00470795939385
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.624849866411745
FCF margin (%): 7.20744699479579
Rule of 40 score: 7.20744699479579
Financial ratios for CONFIPET.NS — annual report dated 2023-03-31
Total revenue: 268533495.73690623
Gross profit: 38056029.23264312
Operating income: 16088915.956151037
Net income: 10244823.386114495
Capital expenditures: 0
Operating cash flow: -15202192.448233861
Depreciation & amortization: 10241169.305724727
Net tangible assets: 85734470.1583435
Owner earnings: 20485992.691839222
Return on net tangible assets (%): 23.894697959879522
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7384896467722291
P/E ratio: 23.949321646760197
Shares outstanding: 332241043
Book value: 108081607.7953715
P/B ratio: 2.2701047430089596
Market cap (USD): 245356570.48830697
Debt to equity: 0.4650138051501662
Current ratio: 1.8263767913966507
Quick ratio: 1.1496992079529882
Effective tax rate (%): 26.746211461417868
Interest coverage ratio: 6.023255813953488
COGS to revenue (%): 85.82820026670778
SG&A to revenue (%): 5.375885624087161
Free cash flow (dilution-adjusted): -15202192.448233861
Buyback yield (%): 0
Retained earnings: 45963459.19610232
Inventory turnover: 6.495108639686953
Receivables turnover: 17.459887542567515
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.92212538656171
FCF margin (%): -5.661190387633467
Revenue growth (%): 42.62826651254543
Rule of 40 score: 36.96707612491196
Financial ratios for CONFIPET.NS — annual report dated 2024-03-31
Total revenue: 323597553.66350883
Gross profit: 42961985.84962226
Operating income: 23870967.741935484
Net income: 12625014.989806931
Capital expenditures: 29386017.508094497
Operating cash flow: 31532557.860654753
Depreciation & amortization: 19224127.5932366
Net tangible assets: 128706079.86569133
Owner earnings: 2463125.0749490336
Return on net tangible assets (%): 1.9137596899224798
Capex to operating income (%): 123.10358685823371
Buffett classification: The Gruesome
Stock price: 1.005038387715931
P/E ratio: 26.448681641912703
Shares outstanding: 332241043
Book value: 151991845.5450294
P/B ratio: 2.196927085084002
Market cap (USD): 333915002.1897793
Debt to equity: 0.4991084531267258
Current ratio: 2.0100294759407418
Quick ratio: 1.6220763312023887
Effective tax rate (%): 26.58967778728258
Interest coverage ratio: 2.9359882005899705
COGS to revenue (%): 86.72363701046515
SG&A to revenue (%): 4.190136669532477
Free cash flow (dilution-adjusted): 2146540.352560259
Buyback yield (%): 0.036631125812604665
Retained earnings: 57270655.953951314
Inventory turnover: 11.545808870689232
Receivables turnover: 17.093051244695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.848527416013903
FCF margin (%): 0.6633363967863389
Revenue growth (%): 20.5054709378048
Rule of 40 score: 21.16880733459114
Financial ratios for CONFIPET.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 5204252.269469661
Net tangible assets: 141004538.93932155
Buffett classification: The Gruesome
Stock price: 1.0284280936454848
Shares outstanding: 332241043
Book value: 164177018.6335404
P/B ratio: 2.0812049416365337
Market cap (USD): 341686022.48327756
Debt to equity: 0.5520884109742522
Current ratio: 2.0422987015202962
Quick ratio: 1.6448717729963998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CONFIPET.NS — quarterly report dated 2024-12-31
Total revenue: 81276372.53759179
Gross profit: 19497610.444107704
Operating income: 3955006.4110036134
Net income: 3576174.379298286
Capital expenditures: 0
Depreciation & amortization: 5466837.626763025
Owner earnings: 9043012.006061312
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8138477678051054
P/E ratio: 18.902436132871575
Shares outstanding: 332241043
Market cap (USD): 270393631.21879005
Effective tax rate (%): 28.295206971677555
Interest coverage ratio: 1.7867298578199053
COGS to revenue (%): 76.01072755173749
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CONFIPET.NS — quarterly report dated 2025-03-31
Total revenue: 108114332.4760346
Gross profit: 16737198.971241523
Operating income: 5515548.281505728
Net income: 3193827.4491465976
Capital expenditures: 0
Net tangible assets: 142598784.19452888
Owner earnings: 3193827.4491465976
Return on net tangible assets (%): 2.239729789553939
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5463881433072704
P/E ratio: 14.20964105807807
Shares outstanding: 332241043
Book value: 169316109.4224924
P/B ratio: 1.072151771230846
Market cap (USD): 181532566.615241
Debt to equity: 0.5282981088564069
Current ratio: 1.9278056704075603
Quick ratio: 1.5603957471943293
Effective tax rate (%): 19.296690307328603
Interest coverage ratio: 2.2737349397590365
COGS to revenue (%): 84.51898227744078
Buyback yield (%): 0
Retained earnings: 64729950.90016366
Inventory turnover: 3.1415136047586514
Receivables turnover: 2.940478840100474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5165216741963183
Revenue growth (%): 33.02061730920604
Rule of 40 score: 33.02061730920604
Financial ratios for CONFIPET.NS — annual report dated 2025-03-31
Total revenue: 367753097.9658639
Gross profit: 57729717.09141921
Operating income: 17484217.909749825
Net income: 10619593.172784662
Capital expenditures: 0
Operating cash flow: 621931.2602291325
Depreciation & amortization: 20432546.177227028
Net tangible assets: 142598784.19452888
Owner earnings: 31052139.35001169
Return on net tangible assets (%): 21.77587945466023
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5463881433072704
P/E ratio: 17.09411685190193
Shares outstanding: 332241043
Book value: 169316109.4224924
P/B ratio: 1.072151771230846
Market cap (USD): 181532566.615241
Debt to equity: 0.5282981088564069
Current ratio: 1.9278056704075603
Quick ratio: 1.5603957471943293
Effective tax rate (%): 22.15271231467992
Interest coverage ratio: 1.9018311291963377
COGS to revenue (%): 84.30204465693505
SG&A to revenue (%): 4.769912517165963
Free cash flow (dilution-adjusted): 621931.2602291325
Buyback yield (%): 0
Retained earnings: 64729950.90016366
Inventory turnover: 10.658494433503476
Receivables turnover: 10.002098502432355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.977341703959334
FCF margin (%): 0.16911652510045266
Revenue growth (%): 13.645203371429055
Rule of 40 score: 13.814319896529508
Financial ratios for CONFIPET.NS — quarterly report dated 2025-06-30
Total revenue: 130118183.94570561
Gross profit: 20264451.20524222
Operating income: 4863093.8450737195
Net income: 2392932.3660191903
Capital expenditures: 0
Depreciation & amortization: 4825649.426632343
Owner earnings: 7218581.792651533
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6096419377486544
P/E ratio: 22.105154195751677
Shares outstanding: 332241043
Market cap (USD): 202548073.254154
Effective tax rate (%): 25.22851919561243
Interest coverage ratio: 1.97622444127437
COGS to revenue (%): 84.42611893991851
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 20.35239081233614
Rule of 40 score: 20.35239081233614
Financial ratios for CONFIPET.NS — quarterly report dated 2025-09-30
Total revenue: 110824126.26832017
Gross profit: 21236753.100338217
Operating income: 4613303.269447576
Net income: 2301014.6561443065
Capital expenditures: 0
Depreciation & amortization: 4680947.012401353
Net tangible assets: 142981961.66854566
Owner earnings: 6981961.66854566
Return on net tangible assets (%): 4.883106643012025
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5080045095828636
P/E ratio: 14.722671071893096
Shares outstanding: 332241043
Book value: 169023675.31003386
P/B ratio: 0.998558029240148
Market cap (USD): 168779948.11251408
Debt to equity: 0.5538406125770389
Current ratio: 2.2869353641002954
Quick ratio: 1.9433744647907352
Effective tax rate (%): 25.45653761869978
Interest coverage ratio: 1.6965174129353235
COGS to revenue (%): 80.83742790002137
Buyback yield (%): 0
Inventory turnover: 3.6543573235226487
Receivables turnover: 2.687728987805545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0296108920467226
Revenue growth (%): -14.828102492912338
Rule of 40 score: -14.828102492912338
Financial ratios for CONFIPET.NS — quarterly report dated 2025-12-31
Total revenue: 155272362.70468977
Gross profit: 19134454.717611674
Operating income: 4816753.926701571
Net income: 2370502.395009469
Capital expenditures: 0
Depreciation & amortization: 4771081.653113512
Owner earnings: 7141584.048122982
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.4071516096691545
P/E ratio: 13.18666645659969
Shares outstanding: 332241043
Market cap (USD): 135272475.45560876
Effective tax rate (%): 22.193784277879345
Interest coverage ratio: 1.7316780136163394
COGS to revenue (%): 87.67684449163487
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 40.10700371212891
Rule of 40 score: 40.10700371212891
Financial ratios for COPC.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.011216216216216216
Shares outstanding: 175045265
Market cap (USD): 1963345.539864865
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COPC.L — annual report dated 2022-09-30
Total revenue: 45185555.55555555
Gross profit: 4083333.333333333
Operating income: -17777.777777777777
Net income: -8016666.666666666
Capital expenditures: 9835555.555555556
Operating cash flow: 2067777.7777777778
Depreciation & amortization: 5224444.444444444
Net tangible assets: 7482222.222222222
Owner earnings: -12627777.777777778
Return on net tangible assets (%): -168.7704187704188
Buffett classification: The Gruesome
Stock price: 0.004333333333333333
Shares outstanding: 175045265
Book value: 19942222.222222224
P/B ratio: 0.038036356892132826
Market cap (USD): 758529.4816666667
Debt to equity: 2.494818364163138
Current ratio: 0.5289095204542629
Quick ratio: 0.4954200688025863
Interest coverage ratio: -0.007980049875311722
COGS to revenue (%): 90.9631888263211
Free cash flow (dilution-adjusted): -8690000
Buyback yield (%): 0
Retained earnings: -105500000
Inventory turnover: 45.78217821782179
Receivables turnover: 199.34803921568627
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.03364949841216429
FCF margin (%): -19.23180957533135
Rule of 40 score: -19.23180957533135
Financial ratios for COPC.L — annual report dated 2023-09-30
Total revenue: 55481707.317073174
Gross profit: 2314634.1463414636
Operating income: -2343902.43902439
Net income: -8142682.926829269
Capital expenditures: 8347560.975609757
Operating cash flow: 2539024.390243903
Depreciation & amortization: 6793902.439024391
Net tangible assets: 229268.29268292684
Owner earnings: -9696341.463414636
Return on net tangible assets (%): -4229.255319148937
Buffett classification: The Gruesome
Stock price: 0.0039024390243902443
Shares outstanding: 175045265
Book value: 13829268.292682916
P/B ratio: 0.04939548924162262
Market cap (USD): 683103.4731707318
Debt to equity: 3.9551146384479754
Current ratio: 0.1939682421628054
Quick ratio: 0.15388048045814584
Interest coverage ratio: -0.7781376518218623
COGS to revenue (%): 95.82811297944829
Free cash flow (dilution-adjusted): -5892682.926829269
Buyback yield (%): 0
Retained earnings: -123851219.51219513
Inventory turnover: 40.442486085343226
Receivables turnover: 295.42207792207796
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.83558507560319
FCF margin (%): -10.620947356852401
Revenue growth (%): 22.786378600255393
Rule of 40 score: 12.165431243402992
Financial ratios for COPC.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 24533333.333333332
Buffett classification: The Gruesome
Stock price: 0.0024
Shares outstanding: 175045265
Book value: 39320000
P/B ratio: 0.010684349847405898
Market cap (USD): 420108.63599999994
Debt to equity: 1.1695489996609019
Current ratio: 0.6338197321803879
Quick ratio: 0.5650033027082207
Buyback yield (%): 0
Retained earnings: -139365333.33333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COPC.L — annual report dated 2024-09-30
Total revenue: 65981333.333333336
Gross profit: 4618666.666666667
Operating income: -402666.6666666667
Net income: -4476000
Capital expenditures: 5756000
Operating cash flow: 3081333.3333333335
Depreciation & amortization: 7336000
Net tangible assets: 24533333.333333332
Owner earnings: -2896000
Return on net tangible assets (%): -11.804347826086957
Buffett classification: The Gruesome
Stock price: 0.0024
Shares outstanding: 175045265
Book value: 39320000
P/B ratio: 0.010684349847405898
Market cap (USD): 420108.63599999994
Debt to equity: 1.1695489996609019
Current ratio: 0.6338197321803879
Quick ratio: 0.5650033027082207
Interest coverage ratio: -0.12407559572719803
COGS to revenue (%): 93.00004041547103
Free cash flow (dilution-adjusted): -3196000
Buyback yield (%): 0
Retained earnings: -139365333.33333334
Inventory turnover: 40.1588132635253
Receivables turnover: 202.81147540983608
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5288781478757312
FCF margin (%): -4.843794204421452
Revenue growth (%): 18.924482543869285
Rule of 40 score: 14.080688339447832
Financial ratios for COPC.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 21463636.363636363
Buffett classification: The Gruesome
Stock price: 0.0018181818181818184
Shares outstanding: 175045265
Book value: 35866233.76623376
P/B ratio: 0.008873641995872112
Market cap (USD): 318264.1181818182
Debt to equity: 1.2118622587536665
Current ratio: 0.6610289937464469
Quick ratio: 0.5777430358158044
Buyback yield (%): 0
Retained earnings: -138177922.07792208
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COPC.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 21918918.91891892
Buffett classification: The Gruesome
Stock price: 0.0013513513513513514
Shares outstanding: 175045265
Book value: 36905405.4054054
P/B ratio: 0.006409566642255585
Market cap (USD): 236547.6554054054
Debt to equity: 1.1883559135847677
Current ratio: 0.6099894905691686
Quick ratio: 0.5439460147132033
Buyback yield (%): 0
Retained earnings: -144194594.5945946
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COPC.L — annual report dated 2025-09-30
Total revenue: 70778378.37837838
Gross profit: 7660810.810810811
Operating income: 1529729.7297297297
Net income: -3693243.243243243
Capital expenditures: 2205405.4054054054
Operating cash flow: 10487837.837837838
Depreciation & amortization: 8044594.594594595
Net tangible assets: 21918918.91891892
Owner earnings: 2145945.945945947
Capex to operating income (%): 144.1696113074205
Buffett classification: The Gruesome
Stock price: 0.0013513513513513514
Shares outstanding: 175045265
Book value: 36905405.4054054
P/B ratio: 0.006409566642255585
Market cap (USD): 236547.6554054054
Debt to equity: 1.1883559135847677
Current ratio: 0.6099894905691686
Quick ratio: 0.5439460147132033
Interest coverage ratio: 0.5260223048327137
COGS to revenue (%): 89.17634030853827
Free cash flow (dilution-adjusted): 7535135.135135136
Buyback yield (%): 0
Retained earnings: -144194594.5945946
Inventory turnover: 39.118090452261306
Receivables turnover: 631.0361445783133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.166755991118597
FCF margin (%): 10.64609744921338
Revenue growth (%): 7.270306316501193
Rule of 40 score: 17.916403765714573
Financial ratios for CPBI — annual report dated 2024-03-31
Total revenue: 17074000
Gross profit: -6949000
Operating income: -10612000
Net income: 3759000
Capital expenditures: 2281000
Operating cash flow: 5708000
Depreciation & amortization: 518000
Net tangible assets: 77874000
Owner earnings: 1996000
Return on net tangible assets (%): 2.5631147751496006
Buffett classification: The Gruesome
Stock price: 10.22
P/E ratio: 11.372168379888269
Shares outstanding: 4182777
Book value: 78277000
P/B ratio: 0.5461116412228368
Market cap (USD): 42747980.940000005
Debt to equity: 0
Current ratio: 67.0709232096635
Quick ratio: 67.0709232096635
Effective tax rate (%): 18.917169974115616
Interest coverage ratio: -1.635130970724191
COGS to revenue (%): 40.69930889071102
SG&A to revenue (%): 55.540588028581475
Free cash flow (dilution-adjusted): 3266000
Buyback yield (%): 0
Retained earnings: 47130000
Receivables turnover: 7.591818586038239
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.319649036139048
FCF margin (%): 19.128499472882744
Rule of 40 score: 19.128499472882744
Financial ratios for CPBI — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 131000
Buffett classification: The Gruesome
Stock price: 12.56
Shares outstanding: 4182777
Market cap (USD): 52535679.120000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPBI — quarterly report dated 2024-12-31
Total revenue: 4722000
Net income: 951000
Capital expenditures: 2154000
Operating cash flow: 674000
Depreciation & amortization: 130000
Net tangible assets: 80885000
Owner earnings: -1073000
Return on net tangible assets (%): -1.3265747666440006
Buffett classification: The Gruesome
Stock price: 14.96
P/E ratio: 16.449617223974762
Shares outstanding: 4182777
Book value: 81266000
P/B ratio: 0.7699941417074792
Market cap (USD): 62574343.92
Debt to equity: 0
Effective tax rate (%): 20.151133501259448
COGS to revenue (%): 0
SG&A to revenue (%): 57.856840321897494
Free cash flow (dilution-adjusted): -1553000
Buyback yield (%): 0.2189395707850356
Retained earnings: 49893000
Receivables turnover: 1.651626442812172
Capitalized R&D asset: 0
FCF margin (%): -32.88860652265989
Rule of 40 score: -32.88860652265989
Financial ratios for CPBI — annual report dated 2025-03-31
Total revenue: 18838000
Net income: 3654000
Capital expenditures: 7526000
Operating cash flow: 4459000
Depreciation & amortization: 455000
Net tangible assets: 82952000
Owner earnings: -3417000
Return on net tangible assets (%): -4.119249686565725
Buffett classification: The Gruesome
Stock price: 14.92
P/E ratio: 17.07910039408867
Shares outstanding: 4182777
Book value: 83332000
P/B ratio: 0.7488963764220228
Market cap (USD): 62407032.839999996
Debt to equity: 0
Effective tax rate (%): 19.21291178421402
COGS to revenue (%): 0
SG&A to revenue (%): 58.79074211699756
Free cash flow (dilution-adjusted): -3427000
Buyback yield (%): 0.6617843874405229
Retained earnings: 50652000
Receivables turnover: 6.074814575943244
Capitalized R&D asset: 0
FCF margin (%): -18.19195243656439
Revenue growth (%): 10.331498184373903
Rule of 40 score: -7.860454252190486
Financial ratios for CPBI — quarterly report dated 2025-03-31
Total revenue: 4990000
Net income: 848000
Capital expenditures: 2728000
Operating cash flow: 2081000
Depreciation & amortization: 66000
Net tangible assets: 82952000
Owner earnings: -1814000
Return on net tangible assets (%): -2.1868068280451345
Buffett classification: The Gruesome
Stock price: 14.92
P/E ratio: 18.398299775943396
Shares outstanding: 4182777
Book value: 83332000
P/B ratio: 0.7488963764220228
Market cap (USD): 62407032.839999996
Debt to equity: 0
Effective tax rate (%): 20.375586854460092
COGS to revenue (%): 0
SG&A to revenue (%): 59.8997995991984
Free cash flow (dilution-adjusted): -863000
Buyback yield (%): 0.4422578472968144
Retained earnings: 50652000
Receivables turnover: 1.6091583360206385
Capitalized R&D asset: 0
FCF margin (%): -17.294589178356716
Revenue growth (%): 5.675561202880135
Rule of 40 score: -11.61902797547658
Financial ratios for CPBI — quarterly report dated 2025-06-30
Total revenue: 5081000
Net income: 988000
Capital expenditures: 670000
Operating cash flow: -96000
Depreciation & amortization: 195000
Net tangible assets: 84265000
Owner earnings: 513000
Return on net tangible assets (%): 0.608793686583991
Buffett classification: The Gruesome
Stock price: 15.12
P/E ratio: 22.692353153928956
Shares outstanding: 4182777
Book value: 84646000
P/B ratio: 0.7471538907922405
Market cap (USD): 63243588.239999995
Debt to equity: 0.1000165394702644
Effective tax rate (%): 19.609438567941414
COGS to revenue (%): 0
SG&A to revenue (%): 59.771698484550285
Free cash flow (dilution-adjusted): -1000000
Buyback yield (%): 0.4111088684806098
Retained earnings: 51554000
Receivables turnover: 1.640619954794963
Capitalized R&D asset: 0
FCF margin (%): -19.681165124975397
Revenue growth (%): 1.8236472945891786
Rule of 40 score: -17.857517830386218
Financial ratios for CPBI — quarterly report dated 2025-09-30
Total revenue: 5194000
Net income: 882000
Capital expenditures: 242000
Operating cash flow: 1130000
Depreciation & amortization: 283000
Net tangible assets: 85778000
Owner earnings: 923000
Return on net tangible assets (%): 1.0760334817785446
Buffett classification: The Gruesome
Stock price: 16.3
P/E ratio: 18.582519787408014
Shares outstanding: 4182777
Book value: 86180000
P/B ratio: 0.791126306567649
Market cap (USD): 68179265.10000001
Debt to equity: 0.09863077280111394
Effective tax rate (%): 20.896860986547086
COGS to revenue (%): 0
SG&A to revenue (%): 58.66384289564882
Free cash flow (dilution-adjusted): 646000
Buyback yield (%): 0.1320049429514898
Retained earnings: 52405000
Receivables turnover: 1.3636124967182988
Capitalized R&D asset: 0
FCF margin (%): 12.437427801309203
Revenue growth (%): 2.22397165912222
Rule of 40 score: 14.661399460431424
Financial ratios for CPBI — quarterly report dated 2025-12-31
Total revenue: 5490000
Net income: 1175000
Capital expenditures: 60000
Operating cash flow: 2287000
Depreciation & amortization: 259000
Net tangible assets: 87348000
Owner earnings: 1374000
Return on net tangible assets (%): 1.5730182717406238
Buffett classification: The Gruesome
Stock price: 16.92
P/E ratio: 18.1794469149756
Shares outstanding: 4182777
Book value: 87758000
P/B ratio: 0.8064516834932428
Market cap (USD): 70772586.84
Debt to equity: 0
Effective tax rate (%): 20.33898305084746
COGS to revenue (%): 0
SG&A to revenue (%): 55.95628415300546
Free cash flow (dilution-adjusted): 1980000
Buyback yield (%): 0.27411743538297945
Retained earnings: 53507000
Receivables turnover: 1.654611211573237
Capitalized R&D asset: 0
FCF margin (%): 36.0655737704918
Revenue growth (%): 5.698883326915672
Rule of 40 score: 41.76445709740747
Financial ratios for DGR.AX — annual report dated 2021-06-30
Total revenue: 1082706.7669172932
Gross profit: 1082706.7669172932
Operating income: -2480187.9699248117
Net income: -797708.2706766917
Capital expenditures: 8434.586466165412
Depreciation & amortization: 332659.3984962406
Net tangible assets: 102951021.80451128
Owner earnings: -473483.4586466165
Return on net tangible assets (%): -0.4599113737265195
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 1043695978
Book value: 104699743.60902256
P/B ratio: 0.44970529496740114
Market cap (USD): 47084029.082706764
Debt to equity: 0.0109097149766451
Current ratio: 2.0673956261541453
Quick ratio: 2.0673956261541453
Interest coverage ratio: -8.952483566826428
COGS to revenue (%): 0
SG&A to revenue (%): 256.32
Free cash flow (dilution-adjusted): -2351491.729323308
Buyback yield (%): 0.9906253242902375
Retained earnings: -20104233.082706764
Receivables turnover: 2.0455969236495153
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.0152252585211468
FCF margin (%): -217.18638888888887
Rule of 40 score: -217.18638888888887
Financial ratios for DGR.AX — annual report dated 2022-06-30
Total revenue: 524924.827586207
Gross profit: 524924.827586207
Operating income: -2449135.1724137934
Net income: -6303800
Capital expenditures: 9744.827586206897
Depreciation & amortization: 306139.3103448276
Net tangible assets: 100346109.65517242
Owner earnings: -6007405.517241379
Return on net tangible assets (%): -5.98668502235425
Buffett classification: The Gruesome
Stock price: 0.041379310344827586
Shares outstanding: 1043695978
Book value: 102572682.06896552
P/B ratio: 0.4210421226021267
Market cap (USD): 43187419.779310346
Debt to equity: 0.02838581965922243
Current ratio: 2.806248565421033
Quick ratio: 2.806248565421033
Interest coverage ratio: -60.10300240327658
COGS to revenue (%): 0
SG&A to revenue (%): 483.8838007675319
Free cash flow (dilution-adjusted): -3747997.931034483
Buyback yield (%): 0.027100803870301015
Retained earnings: -24744234.482758623
Receivables turnover: 0.345489182881073
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9952194908530105
FCF margin (%): -714.0066032443398
Revenue growth (%): -51.5173596743295
Rule of 40 score: -765.5239629186692
Financial ratios for DGR.AX — annual report dated 2023-06-30
Total revenue: 302200.66225165565
Gross profit: 302200.66225165565
Operating income: -4106556.953642384
Net income: -6306988.741721855
Capital expenditures: 13374.172185430463
Depreciation & amortization: 293117.880794702
Net tangible assets: 69924033.77483444
Owner earnings: -6027245.033112583
Return on net tangible assets (%): -8.61970442454906
Buffett classification: The Gruesome
Stock price: 0.026490066225165563
Shares outstanding: 1043695978
Book value: 122243575.49668874
P/B ratio: 0.2261679230489118
Market cap (USD): 27647575.57615894
Debt to equity: 0.021246989352746982
Current ratio: 0.808815030462141
Quick ratio: 0.808815030462141
Interest coverage ratio: -57.56713023134911
COGS to revenue (%): 0
SG&A to revenue (%): 769.8822982843293
Free cash flow (dilution-adjusted): -5443662.913907285
Buyback yield (%): 0
Retained earnings: -30068008.609271523
Receivables turnover: 0.1751938341635713
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1476257454556906
FCF margin (%): -1801.340497849111
Revenue growth (%): -42.429725863552136
Rule of 40 score: -1843.7702237126632
Financial ratios for DR.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.433070866141732
Shares outstanding: 17550249
Market cap (USD): 112901995.53543307
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DR.TO — annual report dated 2022-12-31
Total revenue: 312169852.9411765
Gross profit: 206342647.05882353
Operating income: 37858823.52941176
Net income: 9040441.176470587
Capital expenditures: 4939705.882352941
Operating cash flow: 41921323.52941176
Depreciation & amortization: 15266911.764705881
Net tangible assets: -40138970.58823529
Owner earnings: 19367647.058823526
Return on net tangible assets (%): -48.25147923574346
Capex to operating income (%): 13.047700435052828
Buffett classification: The Great
Stock price: 5.352941176470588
P/E ratio: 10.391688712484749
Shares outstanding: 17550249
Book value: 84332352.94117647
P/B ratio: 1.1139906246294422
Market cap (USD): 93945450.52941176
Debt to equity: 1.2464164893802532
Current ratio: 1.3744572040682341
Quick ratio: 1.2681786244946385
Effective tax rate (%): 29.75489916014397
Interest coverage ratio: 3.9956541983548033
COGS to revenue (%): 33.900520785488666
SG&A to revenue (%): 46.68767709886445
Free cash flow (dilution-adjusted): 37472058.82352941
Buyback yield (%): 30.04246533782781
Retained earnings: -202422794.11764705
Inventory turnover: 15.59824428308226
Receivables turnover: 6.5692512417410684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.695173418748194
FCF margin (%): 12.003740422234312
Rule of 40 score: 12.003740422234312
Financial ratios for DR.TO — annual report dated 2023-12-31
Total revenue: 257254545.45454544
Gross profit: 166068939.39393938
Operating income: 37254545.45454545
Net income: 33332575.757575758
Capital expenditures: 12161363.636363637
Operating cash flow: 55086363.63636363
Depreciation & amortization: 16315909.09090909
Net tangible assets: -34762878.78787879
Owner earnings: 37487121.2121212
Return on net tangible assets (%): -107.83664218624007
Capex to operating income (%): 32.64397266959493
Buffett classification: The Good
Stock price: 6.4015151515151505
P/E ratio: 3.3705221493670305
Shares outstanding: 17550249
Book value: 89623484.84848481
P/B ratio: 1.2535574250019021
Market cap (USD): 112348184.88636363
Debt to equity: 0.9873714106996444
Current ratio: 1.238618145875773
Quick ratio: 1.1300370053398585
Effective tax rate (%): 17.370380979661988
Interest coverage ratio: 3.0765765765765765
COGS to revenue (%): 35.445673428039676
SG&A to revenue (%): 44.68219190991118
Free cash flow (dilution-adjusted): 43285606.06060606
Buyback yield (%): 5.004733524101409
Retained earnings: -199111363.63636363
Inventory turnover: 13.362011545293074
Receivables turnover: 4.876443219024642
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.084464776922967
FCF margin (%): 16.825982990552927
Revenue growth (%): -17.59148328041112
Rule of 40 score: -0.765500289858192
Financial ratios for DR.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.6
Shares outstanding: 17550249
Market cap (USD): 168482390.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DR.TO — annual report dated 2024-12-31
Total revenue: 172089510.4895105
Gross profit: 121079020.97902098
Operating income: 36622377.62237763
Net income: 73819580.41958043
Capital expenditures: 4942657.342657343
Operating cash flow: 58240559.44055945
Depreciation & amortization: 13544755.244755246
Net tangible assets: 16918181.81818182
Owner earnings: 82421678.32167833
Return on net tangible assets (%): 487.178109370479
Capex to operating income (%): 13.496276494176055
Buffett classification: The Great
Stock price: 10.552447552447553
P/E ratio: 2.5087934807032832
Shares outstanding: 17550249
Book value: 103113286.71328673
P/B ratio: 1.7960641931611643
Market cap (USD): 185198082.1048951
Debt to equity: 0.5014309741475191
Current ratio: 1.8587617623582053
Quick ratio: 1.7934996458644843
Effective tax rate (%): -14.233982627630116
Interest coverage ratio: 4.484884816305558
COGS to revenue (%): 29.64183544098046
SG&A to revenue (%): 47.37736094405253
Free cash flow (dilution-adjusted): 53469930.06993007
Buyback yield (%): 6.273381282426752
Retained earnings: -136627972.02797204
Inventory turnover: 12.565891472868218
Receivables turnover: 4.822040208488459
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.350113660650102
FCF margin (%): 31.070998992230418
Revenue growth (%): -33.10535672540054
Rule of 40 score: -2.034357733170122
Financial ratios for DR.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.552447552447553
Shares outstanding: 17550249
Market cap (USD): 185198082.1048951
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DR.TO — quarterly report dated 2025-03-31
Total revenue: 42347552.44755245
Gross profit: 29548951.04895105
Operating income: 7453146.853146854
Net income: 6279720.27972028
Capital expenditures: 548951.048951049
Operating cash flow: 11017482.517482517
Depreciation & amortization: 2984615.384615385
Net tangible assets: -12003496.503496503
Owner earnings: 8715384.615384616
Return on net tangible assets (%): -72.6070492280804
Capex to operating income (%): 7.365359354475511
Buffett classification: The Great
Stock price: 11.356643356643357
P/E ratio: 7.934745093541202
Shares outstanding: 17550249
Book value: 73227972.02797204
P/B ratio: 2.7218003338553793
Market cap (USD): 199311918.71328673
Debt to equity: 0.6790366324152947
Current ratio: 1.4482638021483887
Quick ratio: 1.3720209842618034
Effective tax rate (%): -9.878466812090995
Interest coverage ratio: 2.0922654102866116
COGS to revenue (%): 30.222765328533445
SG&A to revenue (%): 47.33556814241128
Free cash flow (dilution-adjusted): 10468531.468531469
Buyback yield (%): 16.06400797512775
Retained earnings: -134872727.27272728
Inventory turnover: 2.998361730013106
Receivables turnover: 1.3725521305530373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.985382510466122
FCF margin (%): 24.72051125386
Rule of 40 score: 24.72051125386
Financial ratios for DR.TO — quarterly report dated 2025-06-30
Total revenue: 58800729.927007295
Gross profit: 39091970.80291971
Operating income: 8743065.693430657
Net income: 7035766.423357664
Capital expenditures: 880291.9708029196
Operating cash flow: 1065693.4306569342
Depreciation & amortization: 2930656.934306569
Net tangible assets: -15584671.532846713
Owner earnings: 9086131.386861313
Return on net tangible assets (%): -58.301718889045006
Capex to operating income (%): 10.068458841208884
Buffett classification: The Great
Stock price: 11.27737226277372
P/E ratio: 14.86394719853701
Shares outstanding: 17550249
Book value: 73500000
P/B ratio: 2.6927985207805745
Market cap (USD): 197920691.27737224
Debt to equity: 0.6716619494513133
Current ratio: 1.5841974914116803
Quick ratio: 1.4806423264360473
Effective tax rate (%): 18.424170616113745
Interest coverage ratio: 6.75959367945824
COGS to revenue (%): 33.51788174832727
SG&A to revenue (%): 46.629094926573735
Free cash flow (dilution-adjusted): 185401.4598540146
Buyback yield (%): 2.584165661071902
Retained earnings: -138309489.0510949
Inventory turnover: 4.166178058941521
Receivables turnover: 1.8459863883223722
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.659236300755007
FCF margin (%): 0.3153046910882978
Revenue growth (%): 38.85272354248134
Rule of 40 score: 39.16802823356964
Financial ratios for DR.TO — quarterly report dated 2025-09-30
Total revenue: 59396402.87769785
Gross profit: 38981294.96402878
Operating income: 8751798.56115108
Net income: 9301438.848920863
Capital expenditures: 785611.5107913669
Operating cash flow: 10012230.215827338
Depreciation & amortization: 2802158.273381295
Net tangible assets: -8125899.28057554
Owner earnings: 11317985.61151079
Return on net tangible assets (%): -139.2828685258964
Capex to operating income (%): 8.976572133168927
Buffett classification: The Great
Stock price: 10.007194244604317
P/E ratio: 7.765368037330396
Shares outstanding: 17550249
Book value: 79199280.57553957
P/B ratio: 2.2175548755983905
Market cap (USD): 175628750.78417268
Debt to equity: 0.5912959750015896
Current ratio: 1.7910225539032774
Quick ratio: 1.6747238203775527
Effective tax rate (%): 19.122982609783563
Interest coverage ratio: 5.577716643741403
COGS to revenue (%): 34.37094996426884
SG&A to revenue (%): 46.176766269788395
Free cash flow (dilution-adjusted): 9226618.705035971
Buyback yield (%): 2.343481531214311
Retained earnings: -131325899.28057554
Inventory turnover: 4.4850640113798
Receivables turnover: 1.8638477514899765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.655929776273456
FCF margin (%): 15.533968823052044
Revenue growth (%): 1.013036660310162
Rule of 40 score: 16.547005483362206